Industry & Business

Fusion Antibodies Doubling Workforce as it Targets Global Business

 Breaking News
  • Greencore to Divest US Business in $1 Billion Deal Greencore Group, the Irish and UK convenience food business, has agreed to sell its entire US business to an affiliate of Hearthside Food Solutions for US$1.075 billion (£817 million) on a cash and debt-free basis. Hearthside is a major US contract food manufacturer with a heritage in US food industry outsourcing. The disposal will leave [...]...
  • Research and Innovation Critical to Business Success Post Brexit The Managing Director of the Industry Research and Development Group (IRDG) says increased investment in research and innovation by both the business sector and the State is critical in order for Irish businesses to survive the hard hitting impact of Brexit. Denis Hayes says despite budget 2019 proposals State expenditure on research and innovation will [...]...
  • Irish Distillers to Invest €150 Million in Sites in Cork and Dublin Irish Distillers has announced investment of over €150 million in its sites in Cork and Dublin to meet demand for its products as the Irish whiskey renaissance continues apace. This is accelerated by the continued growth of the company’s flagship Jameson brand, which is now in double or triple-digit growth in more than 80 markets [...]...
  • CM Precision Components Opens New Purpose-built Factory in Downpatrick Downpatrick-based CM Precision Components Ltd has officially opened its new 16,000 sq ft manufacturing facility at Invest Northern Ireland’s Killough Road Industrial Estate. The advanced engineering firm has invested almost £1 million in the construction project, to expand its production capabilities and meet the growing demands of its customers. CM Precision Components produces precision machined components for [...]...
  • Arkphire Secures New Investment IT solutions and networking company, Arkphire, has announced that Bregal Milestone, a private capital firm, has completed an investment into the business. The investment by Bregal Milestone comes from their new €400 million pan-European fund dedicated to investing in high-growth European companies. Typical commitments from Bregal Milestone range from €20 million to €60 million. Arkphire provides [...]...

Fusion Antibodies Doubling Workforce as it Targets Global Business

Fusion Antibodies Doubling Workforce as it Targets Global Business
May 28
10:36 2018

Belfast-based Clinical Research firm, Fusion Antibodies has announced plans to create 28 new jobs. This recruitment drive, supported by Invest Northern Ireland, will help Fusion deliver its services to its growing international customer base.

The company’s antibody engineering technology assists in the development of novel biological molecules that are used as innovative drugs for human diseases including cancer, coeliac disease, chronic fungal infections and immunological indications.

Announcing the expansion, Paul Kerr, Managing Director of Fusion Antibodies, said: “Invest NI continues to provide excellent support as we look to expand the business rapidly and to capitalise on our position as a successful international CRO providing a range of antibody engineering services. The work to more than double the capacity of our laboratory and office space is expected to be completed by the end of the summer, ahead of our original schedule. The new employees will include technically skilled staff working to deliver our current services to biopharma companies.

“We are also recruiting scientists with specialised skills to work in our new product development team on the establishment of our antibody affinity maturation service and the creation of a mammalian antibody library. In addition, our growth strategy, focussed on reinvigorating and expanding our new business development and sales function, will benefit from further resource in this area.”

Invest NI has offered Fusion Antibodies £213,000 towards its job creation and marketing activities.

Grainne McVeigh, Invest NI’s Director of Life Sciences, said: “This expansion is an exciting milestone for Fusion Antibodies which is among a dynamic group of companies contributing to our growing Life and Health Sciences sector. Invest NI has been working alongside the business for many years and we are delighted to be helping Fusion Antibodies to scale up its workforce and target market opportunities with drug development and diagnostics companies across the globe.”

CAPTION:

Pictured (L-R): Grainne McVeigh, Director of Life Sciences, Invest Northern Ireland, and Paul Kerr, Managing Director of Fusion Antibodies.

About Author

admin

admin

Related Articles

New Subscriber





Subscribe Here



Advertisements



















National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4